Active

reMYND

Switched

BE0476910101

Rechtspersoon Public limited company 1 establishment

Gaston Geenslaan 1, 3001 Leuven Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Active for

24 year, 6 months

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.
  • A loss two years in a row.
  • The team shrank two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ -217,249

▼ 123% vs 2024

Profit

Caution

€ -6.6 million

▲ 4% vs 2024

Debts

High

€ 3.1 million

▼ 63% vs 2024

reMYND from Leuven, company number BE0476910101, closed financial year 2025 with a result of € -6.6 million after tax. For that financial year reMYND recorded a gross margin of € -217,249 and equity of € -83,639. Compared with financial year 2024, the result moved from € -6.8 million to € -6.6 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.

What happened at reMYND?

What happened at reMYND in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Participatiemaatschappij Vlaanderen NV stepped down as director. NBB
  • NorthboundBio BV stepped down as director. NBB
  • Paul Van Dun stepped down as director. NBB
  • Federale Participatie- en Investeringsmaatschappij NV stepped down as director. NBB
  • R.A.D. LIFE SCIENCES BV stepped down as director. NBB
  • KARGO BV stepped down as director. NBB
  • Korys Management NV stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 6.6 million. Source: NBB ↗

In short

From € 9.3 million loss in 2021 to € 6.6 million loss in 2025.

On average € 25,400 of value added per employee in 2024.

Original PDFs at the National Bank ↗

A new publication or filing at reMYND? We notify you, reason included.

Follow reMYND

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Directors

According to the 2025 annual accounts

Participatiemaatschappij Vlaanderen NV

Director · represented by Tine Bekaert

Also active at: VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK, Arts Gebroeders immobilière, BEDRIJVENCENTRUM VILVOORDE +141 more

since 2025 · until 2030

Korys Management NV

Director · represented by David Devigne

Also active at: Colruyt Group, GINSTBRONNEN, D-DRINKS GROUP +24 more

since 2025 · until 2030

Johan Cardoen

Director

since 2024 · until 2025

NorthboundBio BV

Director · represented by Florien Stam

since 2025 · until 2030

SysteemUnoDue Comm.V.

Director · represented by Rudy De Keyser

since 2024 · until 2025

Paul Van Dun

Director

Also active at: Regionaal Ziekenhuis Heilig Hart Tienen, VersaSense, Zeopore Technologies +4 more

since 2025 · until 2030

Federale Participatie- en Investeringsmaatschappij NV

Director · represented by Goedele Ertveldt

Also active at: Aviapartner Belgium, Société Anonyme Belge de Constructions Aéronautiques, Société Nationale de Construction Aérospatiale +62 more

since 2025 · until 2030

R.A.D. LIFE SCIENCES BV

Director · represented by Rudy Dekeyser

since 2025 · until 2030

KARGO BV

Director · represented by Steven Winderickx

Also active at: STEERIM

since 2025 · until 2030

Establishments

Establishment units

Physical locations of this company

Registered office

Gaston Geenslaan 1

3001 Leuven

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.

DName-iT

€ -71,430 gross margin · 2025

miDiagnostics

€ 24,934 revenue · 2025

ALIGOS BELGIUM

€ 3.2 million gross margin · 2025

Pledge Therapeutics

€ -97,474 gross margin · 2024

PALEO

€ 1.5 million gross margin · 2025

+15 more

Details

Company number
0476.910.101
VAT number
BE 0476.910.101
Registered office
Gaston Geenslaan 1, 3001 Leuven
Names & denominations
reMYND
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
15 February 2002
Peppol
Active · Active since 6 Aug 2025
Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overige technische testen en toetsen

Technische testen en analyses

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of reMYND?
The enterprise number of reMYND is BE0476910101.
What is the address of reMYND?
The registered office of reMYND is located at Gaston Geenslaan 1, 3001 Leuven.
When was reMYND founded?
reMYND was founded on 15 February 2002.
What is the main activity of reMYND?
The main activity of reMYND is "Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied" (NACE code 72109).
Does reMYND have a website?
No website is currently known for reMYND.
How much profit did reMYND make in 2025?
reMYND recorded a loss after taxes of € 6,581,552 in financial year 2025.
What is the revenue of reMYND?
As a small company, reMYND is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -217,249.
How many employees does reMYND have?
According to the 2025 annual accounts, reMYND has 21.1 full-time equivalents (FTE).
Where can I find the annual accounts of reMYND?
reMYND files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of reMYND?
According to the 2025 annual accounts, the directors of reMYND are: Participatiemaatschappij Vlaanderen NV, Korys Management NV, Johan Cardoen, NorthboundBio BV, SysteemUnoDue Comm.V., Paul Van Dun, Federale Participatie- en Investeringsmaatschappij NV, R.A.D. LIFE SCIENCES BV.